These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26275683)

  • 1. Intranasal corticosteroids do not affect intraocular pressure or lens opacity: a systematic review of controlled trials.
    Ahmadi N; Snidvongs K; Kalish L; Sacks R; Tumuluri K; Wilcsek G; Harvey R
    Rhinology; 2015 Dec; 53(4):290-302. PubMed ID: 26275683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal Corticosteroids Do Not Lead to Ocular Changes: A Systematic Review and Meta-analysis.
    Valenzuela CV; Liu JC; Vila PM; Simon L; Doering M; Lieu JEC
    Laryngoscope; 2019 Jan; 129(1):6-12. PubMed ID: 30229924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of intranasal steroids to intraocular pressure.
    Bergmann J; Witmer MT; Slonim CB
    Curr Allergy Asthma Rep; 2009 Jul; 9(4):311-5. PubMed ID: 19656479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular side-effects of topical corticosteroids: what a dermatologist needs to know.
    Daniel BS; Orchard D
    Australas J Dermatol; 2015 Aug; 56(3):164-9. PubMed ID: 25754554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal Corticosteroid Therapy: Systematic Review and Meta-analysis of Reported Safety and Adverse Effects in Children.
    Donaldson AM; Choby G; Kim DH; Marks LA; Lal D
    Otolaryngol Head Neck Surg; 2020 Dec; 163(6):1087-1096. PubMed ID: 32660332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: a meta-analysis.
    Lohia S; Schlosser RJ; Soler ZM
    Allergy; 2013; 68(5):569-79. PubMed ID: 23590215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal Corticosteroid Therapy: Systematic Review and Meta-analysis of Reported Safety and Adverse Effects in Adults.
    Donaldson AM; Choby G; Kim DH; Marks LA; Lal D
    Otolaryngol Head Neck Surg; 2020 Dec; 163(6):1097-1108. PubMed ID: 32539494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of H1 antihistamine addition to intranasal corticosteroid for allergic rhinitis: a systematic review and meta-analysis.
    Seresirikachorn K; Chitsuthipakorn W; Kanjanawasee D; Khattiyawittayakun L; Snidvongs K
    Int Forum Allergy Rhinol; 2018 Oct; 8(10):1083-1092. PubMed ID: 29917324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular effects of topical and systemic corticosteroids.
    David DS; Berkowitz JS
    Lancet; 1969 Jul; 2(7612):149-51. PubMed ID: 4183257
    [No Abstract]   [Full Text] [Related]  

  • 10. Intranasal steroids for acute sinusitis.
    Zalmanovici A; Yaphe J
    Cochrane Database Syst Rev; 2009 Oct; (4):CD005149. PubMed ID: 19821340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal antihistamine is superior to oral H
    Du K; Qing H; Zheng M; Wang X; Zhang L
    Ann Allergy Asthma Immunol; 2020 Nov; 125(5):589-596.e3. PubMed ID: 32650045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Topical Corticosteroids on Early Postoperative Intraocular Pressure Following Combined Cataract and Trabecular Microbypass Surgery.
    Salimi A; Winter A; Li C; Harasymowycz P; Saheb H
    J Ocul Pharmacol Ther; 2019 Sep; 35(7):413-420. PubMed ID: 31373857
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of Intranasal Corticosteroids on Intraocular Pressure and Nerve Fiber Layer Thickness: A Cross-Sectional Study at a Tertiary Care Hospital in Western Saudi Arabia.
    Marzouki HZ; AlThomali RK; Hefni L; Almarzouki N; Alhejaili F; Merdad M; Zawawi F; Alkhatib T
    Cureus; 2021 Feb; 13(2):e13146. PubMed ID: 33564562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal steroids and the myth of mucosal atrophy: a systematic review of original histological assessments.
    Verkerk MM; Bhatia D; Rimmer J; Earls P; Sacks R; Harvey RJ
    Am J Rhinol Allergy; 2015; 29(1):3-18. PubMed ID: 25590306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. iStent with Phacoemulsification versus Phacoemulsification Alone for Patients with Glaucoma and Cataract: A Meta-Analysis.
    Malvankar-Mehta MS; Iordanous Y; Chen YN; Wang WW; Patel SS; Costella J; Hutnik CM
    PLoS One; 2015; 10(7):e0131770. PubMed ID: 26147908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclodestructive procedures for refractory glaucoma.
    Chen MF; Kim CH; Coleman AL
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012223. PubMed ID: 30852841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lens-based glaucoma surgery: using cataract surgery to reduce intraocular pressure.
    Brown RH; Zhong L; Lynch MG
    J Cataract Refract Surg; 2014 Aug; 40(8):1255-62. PubMed ID: 25088622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of different hormone replacement therapy regimens on tear function, intraocular pressure and lens opacity.
    Uncu G; Avci R; Uncu Y; Kaymaz C; Develioğlu O
    Gynecol Endocrinol; 2006 Sep; 22(9):501-5. PubMed ID: 17071534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effectiveness of intranasal corticosteroids in combined allergic rhinitis and asthma syndrome.
    Taramarcaz P; Gibson PG
    Clin Exp Allergy; 2004 Dec; 34(12):1883-9. PubMed ID: 15663563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of cataract among users of intranasal corticosteroids.
    Derby L; Maier WC
    J Allergy Clin Immunol; 2000 May; 105(5):912-6. PubMed ID: 10808171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.